OMX30 1 581 -1,0%  OMXH25 3 968 -1,3%  OMXC20 1 000 -0,9%  Dow 21 580 -0,2%  Nas 5 922 0,0%  EUR 9,6133 0,5%  USD 8,2681 0,3%  Olja 47,9 -2,7%  Guld 1 255 0,6% 

Regeneron Pharmaceuticals Aktie

515,93USD -5,21USD -1,00%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Regeneron Pharmaceuticals Chart - 1 År - BTT

Fundamentala nyckeltal för Regeneron Pharmaceuticals

2016 2017e 2018e 2019e 2020e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 32,83 40,80 34,31 28,27 22,82
Resultat/aktie 11,32 12,84 15,27 18,53 22,96

Nyheter om Regeneron Pharmaceuticals Inc.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Regeneron Pharmaceuticals Inc.

ytterligare analyser

Regeneron Pharmaceuticals Peer Group

pagehit

Lägg till instrument

Vad tycker du?

Profil Regeneron Pharmaceuticals Inc.till bolagsprofilen

Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. Its products include EYLEA injection, which is used for the treatment of neovascular age related macular degeneration; ARCALYST, which is used for the treatment of Cryopyrin-Associated Periodic Syndrome, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome; and PRALUENT Injection for treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL-C. Regeneron Pharmaceuticals was founded by Alferd G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Realtidskurs Regeneron Pharmaceuticals Inc.

Bid 515,79 USD Ask 515,98 USD
Kurstid 21:59 Börsen BTT

Aktiekurs Regeneron Pharmaceuticals Inc. i USDPUSH CHART

Kurs 515,93 USD -5,21 -1,00 %
Kurstid 21:59:57
Datum 21.07.2017
Öppning 519,74
Gårdagen 515,93
Dagshögsta 521,09
Dagslägsta 513,57
52 v. högsta 543,50
52 v. lägsta 325,56
52 v. perf.
Volym (Antal) 31 343
Börsvärde (SEK) 444,06 Mrd
Börsen
Kurs för 515,93 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 4 265,76 SEK.

Till aktien Regeneron Pharmaceuticals

Ticker
ISIN US75886F1075
Index NASDAQ Comp., BX Swiss - USA, S&P 500, NASDAQ 100

Regeneron Pharmaceuticals Nyckeltal

Börsvärde i SEK 444,06 Mrd
Free float % 74,79
Antal aktier mio. 104,38
Cashflow/aktie i lokal valuta 12,81
Bokvärde/aktie i lokal valuta 42,33
60 dagar vola 37,46
PBV 8,78

Regeneron Pharmaceuticals Historiska kurser

2017-07-21 515,93 31 343
2017-07-20 521,14 48 810
2017-07-19 506,70 38 265
2017-07-18 498,02 23 197
2017-07-17 497,80 17 836

Aktier i samma industri med bättre 1 års perf.

Amylin Pharmaceuticals Inc. 264,9 %
Ariad Pharmaceuticals Inc. 260,2 %
Catalyst Pharmaceutical Partners Inc. 246,2 %
Immunomedics Inc. 233,7 %
Exelixis Inc. 205,0 %